The Harvard Business Review Entrepreneur's Handbook: Everything You Need to Launch and Grow Your New Business

Sweetch Health, a chronic condition management platform, has raised $20M in Series A. The round drew participation from Noaber Foundation, Kortex Ventures, Entree Capital, and FinTLV, among others.

HOW’S THE COMPANY PERFORMING?

• Israel-based Sweetch Health leverages  AI to treat people with chronic diseases, like heart disease, diabetes, obesity, hypertension, rheumatoid arthritis, and inflammatory bowel disease. It offers users with personalized recommendations to help manage their chronic conditions. 
• The app was chosen as one of 5, from over 400 prospects, to join the Bayer G4A program, a healthcare accelerator.

Want the full post? Become a CB Insights customer.

If you’re already a customer, log in here.

The post This Entree Capital-Backed Startup Raised $20M To Expand Its Chronic Condition Management Platform appeared first on CB Insights Research.